Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2047685
Max Phase: Preclinical
Molecular Formula: C13H16BrN3O5
Molecular Weight: 374.19
Molecule Type: Small molecule
Associated Items:
ID: ALA2047685
Max Phase: Preclinical
Molecular Formula: C13H16BrN3O5
Molecular Weight: 374.19
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(CCCNC(=O)/C(Cc1ccc(O)c(Br)c1)=N/O)NO
Standard InChI: InChI=1S/C13H16BrN3O5/c14-9-6-8(3-4-11(9)18)7-10(16-21)13(20)15-5-1-2-12(19)17-22/h3-4,6,18,21-22H,1-2,5,7H2,(H,15,20)(H,17,19)/b16-10+
Standard InChI Key: BGUDCWHWRPWMRI-MHWRWJLKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 374.19 | Molecular Weight (Monoisotopic): 373.0273 | AlogP: 0.93 | #Rotatable Bonds: 7 |
Polar Surface Area: 131.25 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.94 | CX Basic pKa: | CX LogP: 0.99 | CX LogD: 0.87 |
Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.16 | Np Likeness Score: 0.34 |
1. Baud MG, Leiser T, Haus P, Samlal S, Wong AC, Wood RJ, Petrucci V, Gunaratnam M, Hughes SM, Buluwela L, Turlais F, Neidle S, Meyer-Almes FJ, White AJ, Fuchter MJ.. (2012) Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets., 55 (4): [PMID:22280363] [10.1021/jm2016182] |
2. Bao Y,Xu Q,Wang L,Wei Y,Hu B,Wang J,Liu D,Zhao L,Jing Y. (2021) Studying Histone Deacetylase Inhibition and Apoptosis Induction of Psammaplin A Monomers with Modified Thiol Group., 12 (1): [PMID:33488962] [10.1021/acsmedchemlett.0c00369] |
Source(1):